Keyword: Vanda Pharmaceuticals

Vanda Pharmaceuticals received a Complete Response Letter from the FDA taking issue with a small study testing Hetlioz in jet lag disorder.

Atopic dermatitis is pitched as a big new market for immune-modifying drugs but is a tough drug development prospect—as Vanda Pharmaceuticals has found out.

Check out Friday's dose of biotech's news of note.